NCT03431896 2026-03-12
MED-hATTR
The Cleveland Clinic
Completed
Clinical Trials
9 trialsNCT04270175 2026-02-27
Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab
Weill Medical College of Cornell University
Phase 2 Active not recruiting
NCT07102212 2025-12-24
FOCUS
Ohio State University Comprehensive Cancer Center
Phase NA Not yet recruiting
NCT06186167 2024-02-20
Amyloidosis Incidence in High-Risk Cardiac Device Patients
Midwest Heart & Vascular Specialists
Unknown
NCT03236792 2022-09-29
Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis
Icahn School of Medicine at Mount Sinai
Phase 1/2 Completed
NCT03923920 2021-12-22
ALF
The Cleveland Clinic
Completed
NCT05150353 2021-12-09
AMYLOCARP
Ramsay Générale de Santé
Phase NA Unknown
NCT01083316 2020-09-25
Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis
Boston Medical Center
Phase 2 Completed
NCT01018927 2017-05-31
Detecting Early Myocardial Infiltration w/Amyloid & Light Chain Deposition Disease in Multiple Myeloma Subjects
University of Arkansas
Terminated